INS and type 2 diabetes mellitus: Diabetes affects approximately 536.6 million people worldwide, with global direct costs estimated at $966 billion in 2021—a staggering 316% increase over the past 15 years.1 Almost 90% of global diabetes cases are type-2 diabetes (T2D) cases, a condition in which the body's ability to properly use insulin to process glucose is impaired.